Wire Stories

Reinsurance Group of America Reinsures 200 Billion JPY of Statutory Reserves From Dai-ichi Life Insurance Company

TOKYO--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA) a leading global life and health reinsurer,…

AM Best Assigns Credit Ratings to FuSure Reinsurance Company Limited

HONG KONG--(BUSINESS WIRE)--#insurance--AM Best has assigned a Financial Strength Rating of A- (Excellent) and a…

Global Bauxite Market (2021 to 2026) – Growth, Trends, COVID-19 Impact and Forecasts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Bauxite Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report…

HighTide Announces First Patient Dosed in Phase 2 PRONTO-PBC Clinical Study Evaluating HTD1801 in Adult Patients with Primary Biliary Cholangitis

SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS WIRE)--HighTide Therapeutics (“HighTide”), a clinical-stage biopharmaceutical company focused on the…

It’s a Free Spins Frenzy at Juicy Stakes

The popular online casino and poker site is running a series of promotions this week…

China Refrigeration Lubricants Market Growth, Trends, COVID-19 Impact, and Forecasts 2021 – 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Refrigeration Lubricants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 -…

beqom Expands Reach into Asia Pacific with Leading Global Investment Services Provider

NYON, Switzerland--(BUSINESS WIRE)--beqom, a cloud-based total compensation software provider, has announced that a leading global…

SchoolMint Makes Strategic Investment in Enquiry Tracker to Bring Education-Focused CRM Technology to US K-12 Market

Strategic investment and partnership makes SchoolMint the exclusive US distributor of Enquiry Tracker’s Education-focused CRM…

Aniview’s Video-ad Solution Doubles Jagran New Media’s Advertising Revenues

Aniview’s platform grants India’s top digital media company full transparency in its video ads and…

BeiGene Announces First Presentation of the Phase 3 ALPINE Trial Comparing BRUKINSA® (Zanubrutinib) to Ibrutinib in Chronic Lymphocytic Leukemia to Be Featured in Presidential Symposium at EHA2021

BRUKINSA demonstrated superior objective response rate by investigator assessment in the planned interim analysis BRUKINSA…